Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Multicenter Study for Assessment of Efficacy and Safety of the Drug JCBC00101, Capsules (PROMOMED RUS LLC, Russia) in Relation to COVID-19 in Adult Population

NCT05595824 is registered in ClinicalTrials.gov with Promomed, LLC as lead sponsor.

NCT NCT05595824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05595824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Multicenter Study for Assessment of Efficacy and Safety of the Drug JCBC00101, Capsules (PROMOMED RUS LLC, Russia) in Relation to COVID-19 in Adult Population
Lead sponsor
Promomed, LLC
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2021
Completion date
March 11, 2022
Enrollment
240 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19